Coronavirus and CNS Preventative/Protective Measures
CONTACT US CALL 800.922.4994
CNS Rehabilitation after COVID-19 Neuro Injury

CNS Rehabilitation after COVID-19 Neuro Injury

CNS can tailor treatment for post-COVID-19 patients who experience neurological complications as a result of the virus. These can include stroke, encephalitis and respiratory distress. Comorbidities related to severe COVID-19 can also be addressed in tandem with neurorehabilitation offered at CNS. Cognitive impairment, memory loss and attention deficits can be associated with infection and are core components of care at all facilities.

COVID-19 Neurological Diagnosis

  • Stroke
  • Critical illness myopathy or neuropathy
  • Anoxic brain injury secondary to cardiac arrest or respiratory distress
  • Encephalitis
  • Guillain-Barre syndrome
     

 

 


Have questions or a potential referral? 
Please contact CNS.
 

Severe COVID-19 Prolonged Illness Comorbidities

  • Post ICU Syndrome
  • Hospital Delirium
  • Motor Weakness
  • Attention Deficit or Impulsivity
  • Cognitive impairment
  • Memory Loss
  • Sundowners Syndrome
  • Depression or Anxiety
  • PTSD or Agoraphobia
  • Insomnia or Fatigue
  • Confusion or Disorientation
  • Loss of Smell or Taste

BIAA Guidance on COVID Vaccines for Persons with Brain Injury

As COVID-19 cases continue to rise, the medical leadership of the Brain Injury Association of America (BIAA) wrote an open letter encouraging all individuals with brain injury to get vaccinated in order to avoid additional neuroinflammatory issues and keep themselves, their families, and their communities safe. Read More


A Patient’s Family Recognizes CNS’ Care in the Era of COVID

At CNS, we believe that families are central to the recovery process, and their efforts have been all the more vital during the current public health crisis. Their trust and support have enabled CNS to meet challenges and continue delivering the highest quality care. Susan Clark, a family member of a patient at CNS Fort Worth, shares her experience with her brother's transition into CNS' post-acute brain injury rehabilitation program during the pandemic.  Read More


 

COVID-19 PANEL DISCUSSION

In partnership with the Brain Injury Association of America (BIAA), CNS recently hosted a live virtual event entitled Neuro Implications of COVID-19: Panel Discussion and Webinar.

The educational webinar discussed various aspects of the neurological, psycho-social, and financial impacts of COVID-19 and welcomed three esteemed speakers, including Mark Pew, Senior Vice President of Product Development and Marketing for Preferred Medical; Deborah Watkins, Founder and Chief Disruption Officer for Care Bridge International; and CNS' Chief Medical Officer Dr. Matthew Ashley.  

Mark Pew

National Speaker & Author
Preferred Medical
 

Deborah Watkins

Founder and Chief Disruption Officer
Care Bridge International
 

Matt Ashley, M.D.

Chief Medical Officer,
Centre for Neuro Skills

Dr. Matt Ashley Discusses COVID-19 Prevention

Read More

Deborah Watkins Addresses Financial Implications of COVID-19

Read More

Dr. Matt Ashley Discusses Long Term Recovery and Return to Work Capabilities Post-COVID

Read More

Dr. Matt Ashley Discusses COVID-19 Neurological Impairments Associated with COVID-19

Read More

Mark Pew Explains the Biopsychosocial Impacts of COVID-19

Read More

How Long Can We Anticipate COVID-19 Related Health Issues Post-COVID?

Read More